Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgeon-performed Outpatient Transoral and Transcervical Ultrasound Compared to MRI for the Diagnostic Workup of Primary Oropharynx Tumors: the SPOT-US Trial

NCT05696314 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05696314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05696314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgeon-performed Outpatient Transoral and Transcervical Ultrasound Compared to MRI for the Diagnostic Workup of Primary Oropharynx Tumors: the SPOT-US Trial
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2023
Completion date
September 1, 2024
Enrollment
201 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

base of the tongue tumor, base of tongue carcinoma, oropharynx cancer, tonsil cancer, tonsil hypertrophy, tonsil lymphoma, tonsil neoplasm, tonsil ulcer